PSI CRO continues growth in Asia-Pacific

By Maggie Lynch contact

- Last updated on GMT

(image: Getty/hansslegers)
(image: Getty/hansslegers)

Related tags: CRO

PSI CRO’s new office in Bangalore, India joins the company’s 50 locations across five continents.

Since 1995, the contract research organization (CRO) PSI CRO has been a private company fully owned by its management. It has grown organically​ by developing new locations driven by clinical trial requests.

Kayt Leonard of PSI CRO told us, “Patients are in need all over the world, and that means clinical trials and our clients are operating all over the world. PSI is global because our mission is global.”

PSI CRO has been operating in India for several years, and having an official location will allow its team to serve clients in a more efficient manner, according to Leonard.

In 2017,  PSI opened offices​ in Sydney, Australia, and Seoul, South Korea. It has offices across five continents.

Leonard furthered, “We don’t have a 1 year, 5-year, or 10-year hiring plan. We grow based off of the work that we conduct combined with the staff and resources we need in order to complete that work successfully for our clients.”

PSI was not able to comment if there are any current trials occurring in Bangalore. 

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more